
WASHINGTON (AP) — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.
The Food and Drug Administration will soon “unleash a massive framework” for how vaccines are tested and approved, according to Commissioner Marty Makary. Details aren’t yet public but the plan is being overseen by the agency’s new vaccine chief, Dr. Vinay Prasad, an outspoken critic of the FDA’s handling of COVID-19 boosters.
Makary and other Trump administration officials already have taken unprecedented steps that raise uncertainty about next fall’s COVID-19 vaccinations, including delaying FDA scientists’ full approval of Novavax’s shot — and then restricting its use to people at higher risk from the virus. They’ve also suggested seasonal tweaks to match the latest circulating virus strains are new products requiring extra testing.
The changes cross multiple health agencies.
The Centers for Disease Control and Prevention hasn’t yet acted on an influential advisory panel’s recent recommendations on use of a new meningitis shot or broader RSV vaccination. A meeting of Kennedy’s “Make America Healthy Again” allies was recently told to expect an end to COVID-19 booster recommendations for children — something that vaccine advisory panel was supposed to debate in June. And researchers around the country lost National Institutes of Health funding to study vaccine hesitancy.
Disclaimer
The information contained in South Florida Reporter is for general information purposes only.
The South Florida Reporter assumes no responsibility for errors or omissions in the contents of the Service.
In no event shall the South Florida Reporter be liable for any special, direct, indirect, consequential, or incidental damages or any damages whatsoever, whether in an action of contract, negligence or other tort, arising out of or in connection with the use of the Service or the contents of the Service. The Company reserves the right to make additions, deletions, or modifications to the contents of the Service at any time without prior notice.
The Company does not warrant that the Service is free of viruses or other harmful components
This article originally appeared here and was republished with permission.